英国化脓性汗腺炎手术治疗:全国诊疗路径调查为THESEUS研究提供依据
该调查通过RSTN向预设外科医生名单发放问卷,描述化脓性汗腺炎(HS)诊疗路径与手术偏好。结果显示仅8/198(4%)医生在正式多学科团队(MDT)工作,一线干预异质、指南推荐治疗(激光与去顶)使用率低、伤口闭合与随访差异大,110/198(56%)未用验证工具判定疗效。作者建议发展MDT、转诊并常规结局测量以减少差异。
要点
- 仅4%(8/198)受访外科医生在正式MDT中管理HS患者。
- 指南推荐的激光与去顶治疗使用率低,一线干预异质。
- 56%(110/198)未用验证结局工具判定治疗成败。
核心结论
- HS手术治疗存在可能不理想的诊疗差异,建议发展MDT、转诊并常规结局测量以减少差异并提高标准化。
研究设计与样本
- 在THESEUS前瞻性队列研究开发中开展定制电子外科医生调查,经RSTN由本地合作者向预设外科医生名单发放,描述HS诊疗路径与手术偏好差异。
主要发现
- 仅8/198(4%)受访外科医生在正式MDT中工作。
- 一线干预存在异质性,指南推荐的激光与去顶治疗使用率低。
- 伤口闭合方法与随访时长存在差异。
- 110/198(56%)受访者未用验证结局工具判定治疗成功或失败。
临床怎么用
- 治疗HS的外科医生可考虑建立MDT或转诊至对HS有兴趣的团队。
- 可考虑常规开展结局测量以促进标准化并改善特定治疗可及性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The evidence-base underpinning treatment efficacy and effectiveness for hidradenitis suppurativa (HS) is limited, as has been highlighted in the wide-ranging research priorities established by a James Lind Alliance priority-setting partnership (PSP). Understanding the landscape of surgical practice is a key step towards tackling undesired variation in care and resolving treatment uncertainties. This survey of current surgical practice aimed to describe care pathways involving surgeons for the management of HS and surgical approaches to management. METHODS: In the development of the prospective cohort Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS), a bespoke electronic surgeon survey was conducted to describe variation in care pathways and surgical preferences in the management of HS. This was disseminated to a pre-defined denominator list of surgeons using local collaborators through the reconstructive surgery trials network (RSTN). RESULTS: Key results were small numbers of surgeons working in formal multidisciplinary teams (MDTs) (8/198, 4%), heterogeneity of first-line intervention, low rates of guideline endorsed treatments (laser and deroofing in particular), variation in wound closure methods and follow-up length, and that over half of respondents do not use well-validated outcome instruments to determine treatment success/failure (110/198, 56%). CONCLUSIONS: This survey demonstrated variation in care, which is likely to be undesirable. Surgeons treating HS patients might consider developing MDTs or referring patients to those with an interest in HS and considering routine outcome measurement. Such steps might reduce variation, increase standardisation of care and improve access to specific treatments.
引用
- Howes R, Ingram JR, Thomas KS, et al. The surgical management of hidradenitis suppurativa in the United Kingdom: a national survey of care pathways informing the THESEUS study. J Plast Reconstr Aesthet Surg. 2021. PMID: 34674976. doi:10.1016/j.bjps.2021.08.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。